Literature DB >> 25027518

Genomic and epigenomic co-evolution in follicular lymphomas.

M Loeffler1, M Kreuz1, A Haake2, D Hasenclever1, H Trautmann3, C Arnold4, K Winter5, K Koch6, W Klapper6, R Scholtysik7, M Rosolowski1, S Hoffmann8, O Ammerpohl2, M Szczepanowski6, D Herrmann3, R Küppers7, C Pott3, R Siebert2.   

Abstract

Follicular lymphoma (FL) with a t(14;18) is a B-cell neoplasm clinically characterized by multiple recurrencies. In order to investigate the clonal evolution of this lymphoma, we studied paired primary and relapse tumor samples from 33 patients with recurrent non-transformed t(14;18)-positive FL. We reconstructed phylogenetic trees of the evolution by taking advantage of the activation-induced cytidine deaminase (AID)-mediated somatic hypermutation (SHM) active in the germinal center reaction using sequences of the clonal VHDHJH rearrangements of the immunoglobulin heavy chain (IGH) locus. Mutational analysis of the IGH locus showed evidence for ongoing somatic mutation and for counter-selection of mutations affecting the BCR conformation during tumor evolution. We further followed evolutionary divergence by targeted sequencing of gene loci affected by aberrant SHM as well as of known driver genes of lymphomagenesis, and by array-based genome-wide chromosomal imbalance and DNA methylation analysis. We observed a wide spectrum of evolutionary patterns ranging from almost no evolution to divergent evolution within recurrent non-transformed t(14;18) FL. Remarkably, we observed a correlation of the magnitude of evolutionary divergence across all genetic and epigenetic levels suggesting co-evolution. The distribution of coding mutations in driver genes and the correlation with SHM suggest CREBBP and AID to be potential modifiers of genetic and epigenetic co-evolution in FL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027518     DOI: 10.1038/leu.2014.209

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  36 in total

1.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

2.  Genetics of follicular lymphoma transformation.

Authors:  Laura Pasqualucci; Hossein Khiabanian; Marco Fangazio; Mansi Vasishtha; Monica Messina; Antony B Holmes; Peter Ouillette; Vladimir Trifonov; Davide Rossi; Fabrizio Tabbò; Maurilio Ponzoni; Amy Chadburn; Vundavalli V Murty; Govind Bhagat; Gianluca Gaidano; Giorgio Inghirami; Sami N Malek; Raul Rabadan; Riccardo Dalla-Favera
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

3.  Improved methods for detecting selection by mutation analysis of Ig V region sequences.

Authors:  Uri Hershberg; Mohamed Uduman; Mark J Shlomchik; Steven H Kleinstein
Journal:  Int Immunol       Date:  2008-04-07       Impact factor: 4.823

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Self-antigen recognition by follicular lymphoma B-cell receptors.

Authors:  Kacey L Sachen; Michael J Strohman; Jonathan Singletary; Ash A Alizadeh; Nicole H Kattah; Chen Lossos; Elizabeth D Mellins; Shoshana Levy; Ronald Levy
Journal:  Blood       Date:  2012-09-28       Impact factor: 22.113

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

7.  Quantifying selection in high-throughput Immunoglobulin sequencing data sets.

Authors:  Gur Yaari; Mohamed Uduman; Steven H Kleinstein
Journal:  Nucleic Acids Res       Date:  2012-05-27       Impact factor: 16.971

8.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

9.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis.

Authors:  Xavier Brochet; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Nucleic Acids Res       Date:  2008-05-24       Impact factor: 16.971

10.  Array-based DNA methylation profiling in follicular lymphoma.

Authors:  C O'Riain; D M O'Shea; Y Yang; R Le Dieu; J G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; C A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; L M Rimsza; E B Smeland; W C Chan; N Johnson; R D Gascoyne; S Reimer; R M Braziel; G W Wright; L M Staudt; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

View more
  25 in total

Review 1.  Epigenetic dysregulation in follicular lymphoma.

Authors:  Shamzah Araf; Jessica Okosun; Lola Koniali; Jude Fitzgibbon; James Heward
Journal:  Epigenomics       Date:  2015-12-23       Impact factor: 4.778

2.  Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development.

Authors:  Sophia Shalhout; Dania Haddad; Angela Sosin; Thomas C Holland; Ayad Al-Katib; Alberto Martin; Ashok S Bhagwat
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

3.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

4.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

5.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.

Authors:  Yanwen Jiang; Ana Ortega-Molina; Huimin Geng; Hsia-Yuan Ying; Katerina Hatzi; Sara Parsa; Dylan McNally; Ling Wang; Ashley S Doane; Xabier Agirre; Matt Teater; Cem Meydan; Zhuoning Li; David Poloway; Shenqiu Wang; Daisuke Ennishi; David W Scott; Kristy R Stengel; Janice E Kranz; Edward Holson; Sneh Sharma; James W Young; Chi-Shuen Chu; Robert G Roeder; Rita Shaknovich; Scott W Hiebert; Randy D Gascoyne; Wayne Tam; Olivier Elemento; Hans-Guido Wendel; Ari M Melnick
Journal:  Cancer Discov       Date:  2016-10-12       Impact factor: 39.397

Review 6.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

Review 7.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

8.  FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

Authors:  Anja Mottok; Vindi Jurinovic; Pedro Farinha; Andreas Rosenwald; Ellen Leich; German Ott; Heike Horn; Wolfram Klapper; Michael Boesl; Wolfgang Hiddemann; Christian Steidl; Joseph M Connors; Laurie H Sehn; Randy D Gascoyne; Eva Hoster; Oliver Weigert; Robert Kridel
Journal:  Blood       Date:  2017-11-09       Impact factor: 22.113

9.  DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.

Authors:  Helene Kretzmer; Stephan H Bernhart; Wei Wang; Andrea Haake; Marc A Weniger; Anke K Bergmann; Matthew J Betts; Enrique Carrillo-de-Santa-Pau; Gero Doose; Jana Gutwein; Julia Richter; Volker Hovestadt; Bingding Huang; Daniel Rico; Frank Jühling; Julia Kolarova; Qianhao Lu; Christian Otto; Rabea Wagener; Judith Arnolds; Birgit Burkhardt; Alexander Claviez; Hans G Drexler; Sonja Eberth; Roland Eils; Paul Flicek; Siegfried Haas; Michael Humme; Dennis Karsch; Hinrik H D Kerstens; Wolfram Klapper; Markus Kreuz; Chris Lawerenz; Dido Lenzek; Markus Loeffler; Cristina López; Roderick A F MacLeod; Joost H A Martens; Marta Kulis; José Ignacio Martín-Subero; Peter Möller; Inga Nage; Simone Picelli; Inga Vater; Marius Rohde; Philip Rosenstiel; Maciej Rosolowski; Robert B Russell; Markus Schilhabel; Matthias Schlesner; Peter F Stadler; Monika Szczepanowski; Lorenz Trümper; Hendrik G Stunnenberg; Ralf Küppers; Ole Ammerpohl; Peter Lichter; Reiner Siebert; Steve Hoffmann; Bernhard Radlwimmer
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

10.  Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.

Authors:  Dominik Nann; Joan Enric Ramis-Zaldivar; Inga Müller; Blanca Gonzalez-Farre; Janine Schmidt; Caoimhe Egan; Julia Salmeron-Villalobos; Guillem Clot; Sven Mattern; Franziska Otto; Barbara Mankel; Dolors Colomer; Olga Balagué; Vanessa Szablewski; Carmen Lome-Maldonado; Lorenzo Leoncini; Stefan Dojcinov; Andreas Chott; Christiane Copie-Bergman; Irina Bonzheim; Falko Fend; Elaine S Jaffe; Elias Campo; Itziar Salaverria; Leticia Quintanilla-Martinez
Journal:  Blood Adv       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.